Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2001-09-04
2002-11-19
Cook, Rebecca (Department: 1614)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
Reexamination Certificate
active
06482838
ABSTRACT:
FIELD OF THE INVENTION
The invention describes novel methods for treating and preventing cognitive impairments caused by traumatic brain injuries by administering a therapeutically effective amount of at least one of the cholinesterase inhibitor compounds described herein. A preferred cholinesterase inhibitor for use in the methods of the invention is donepezil hydrochloride or ARICEPT®.
BACKGROUND OF THE INVENTION
Novel cholinesterase inhibitors are described in U.S. Pat. No. 4,895,841 and WO 98/39000, the disclosures of which are incorporated by reference herein in their entirety. The cholinesterase inhibitors described in U.S. Pat. No. 4,895,841 include donepezil hydrochloride or ARICEPT®, which has proven to be a highly successful drug for the treatment of Alzheimer's disease.
There is a need in the art for new and improved treatments for other diseases, disorders, and syndromes that are characterized by symptoms of dementia and/or cognitive impairments. The invention is directed to these, as well as other, important ends.
SUMMARY OF THE INVENTION
The invention describes novel methods for treating and preventing cognitive impairments caused by traumatic brain injuries (e.g., post head trauma) by administering to a patient a therapeutically effective amount of at least one of the cholinesterase inhibitor compounds described herein.
The present invention is described in more detail below.
REFERENCES:
patent: 4895841 (1990-01-01), Sugimoto et al.
patent: 2001/0036949 (2001-11-01), Coe et al.
patent: 4-21670 (1992-01-01), None
patent: 4-187674 (1992-07-01), None
patent: 97/46527 (1997-12-01), None
patent: WO 98/39000 (1998-09-01), None
patent: WO 01/66096 (2001-09-01), None
Cook Rebecca
Eisai Co. Ltd.
Hale and Dorr LLP
LandOfFree
Methods for treating cognitive impairments caused by... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for treating cognitive impairments caused by..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for treating cognitive impairments caused by... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2989735